# US 2016/0257658 A1 · 2-acylaminothiazoles for the treatment of cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0257658 A1
- Document ID: US20160257658A1
- Status: Published application
- Kind: A1
- Application number: 14/902,319
- Filed: 2014-07-03
- Published: 2016-09-08
- Earliest claimed: 2013-07-04
- Assignees: Universita Degli Studi Di Milano-Bicocca; Universite De Geneve; Universite Claude Bernard Lyon 1
- Applicants: Universita' Degli Studi Di Milano - Bicocca; Université De GenèVe; Université Claude Bernard Lyon 1
- Inventors: Carlo GAMBACORTI-PASSERINI; Luca MOLOGNI; Leonardo SCAPOZZA; William BISSON; Peter GOEKJIAN; Joseph D'ATTOMA
- Web page: https://patentgrep.com/patent/US20160257658A1

## CPC

- C07D 277/46: by carboxylic acids, or sulfur or nitrogen analogues thereof
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 417/14: containing three or more hetero rings
- C07F 7/0812: {comprising a heterocyclic ring}
- C07F 7/1804: {Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896)}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I) as herein described and pharmaceutical compositions thereof. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.

## Claims

### Claim 1

The compounds of formula (I)
wherein:
—R1 is
i equals zero, 1 or 2
Rx and Rx′ can be the same or different and are a C1-C3 linear or branched alkyl;
X is either oxygen or NRy;
Ry is a C1-C3 linear or branched alkyl or propargyl;
Rz is either hydrogen or C1-C3 linear or branched alkyl;
—R2 and —R3 can be the same or different and are hydrogen, linear or branched C1-C3 alkyl or —C≡C—R4, provided that at least one of —R2 and —R3 is —C≡C—R4;
—R4 is hydrogen, —CH2—O—CPh3, cyclohexenyl, C1-C4 alkyl,
Rt and Rt′ can be the same or different and are C1-C3 alkyl optionally substituted with one or more fluorine atoms, C1-C3 alkoxy optionally substituted with one or more fluorine atoms or F;
Ra, Rb and Rc can be the same or different and can be phenyl or C1-C4 linear or branched alkyl;
and pharmaceutically acceptable salts thereof.

### Claim 2 (depends on 1)

The compounds of claim 1 wherein
R2 is hydrogen or linear or branched C1-C3 alkyl; and
R3 is —C≡C—R4.

### Claim 3 (depends on 1)

The compounds of claim 1 wherein
—R2 is —C≡C—R4; and
R3 is hydrogen or linear or branched C1-C3 alkyl.

### Claim 4 (depends on 2)

The compounds of claim 2, wherein —R4 is selected from the list of

### Claim 5 (depends on 2)

The compounds of claim 2, wherein —R4 is selected from the list of

### Claim 6 (depends on 4)

The compounds of claim 4 wherein —R1 is

### Claim 7 (depends on 4)

The compounds of claim 4 wherein —R1 is

### Claim 8 (depends on 4)

The compounds of claim 4 wherein —R1 is selected from the list of

### Claim 9 (depends on 1)

The compounds of claim 1 selected from the list of
4-((4-methylpiperazin-1-yl)methyl)-N-(4-(3-(phenylethynyl)phenyl)thiazol-2-yl)benzamide;
4-((4-methylpiperazin-1-yl)methyl)-N-(4-(3-(p-tolylethynyl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3-((4-methoxyphenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(4-methyl-3-(phenylethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
N-(4-(4-methyl-3-(p-tolylethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-((4-methoxyphenyl)ethynyl)-4-methylphenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(4-methyl-3-((2-(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide:
N-(4-(3-((2-methoxyphenyl)ethynyl)-4-methylphenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3((4-fluorophenyl)ethynyl)-4-methylphenyl)thiazol-2-yl)-4-(4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-methyl-4-(p-tolylethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-methyl-4-((2-(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
4-((4-methylpiperazin-1-yl)methyl)-N-(4-(3-((2-(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3,4-bis((2-(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(4-methyl-3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-methyl-4-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3,4-bis((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
4((4-methylpiperazin-1-yl)methyl)-N-(4-(3-((triethylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
4((4-methylpiperazin-1-yl)methyl)-N-(4-(3-((trimethylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3-(cyclohex-1-en-1-ylethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-(hex-1-yn-1-yl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-(3-((tert-butyldiphenylsilyl)oxy)prop-1-yn-1-yl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
4-((4-methylpiperazin-1-yl)methyl)-N-(4-(3-(3-((triisopropylsilyl)oxy)prop-1-yn-1-yl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3-(3-((tert-butyldimethylsilyl)oxy)prop-1-yn-1-yl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-((tert-butyldimethylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-((tert-butyldiphenylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
5-(4-(4-methylpiperazine-1-carbonyl)phenyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)furan-2-carboxamide;
N-(4-(3-((tert-butyldimethylsilyl)ethynyl)phenyl)thiazol-2-yl)-5-(4-(4-methylpiperazine-1-carbonyl)phenyl)furan-2-carboxamide;
5-(4-(4-methylpiperazine-1-carbonyl)phenyl)-N-(4-(3-(3-((triisopropylsilyl)oxy)prop-1-yn-1-yl)phenyl)thiazol-2-yl)furan-2-carboxamide;
5-(4-(4-methylpiperazine-1-carbonyl)phenyl)-N-(4-(3-((2-(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)furan-2-carboxamide;
4-(4-methylpiperazin-1-yl)methyl)-N-(4-(3-(3-(trityloxy)prop-1-yn-1-yl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3-((2-fluorophenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-((4-fluorophenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-((3,5-bis(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(3-((3,5-bis(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-5-(4-(4-methylpiperazine-1-carbonyl)phenyl)furan-2-carboxamide;
4-(4-methylpiperazin-1-yl)methyl)-N-(4-(4-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
N-(4-(4-((3,5-bis(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
N-(4-(4-((tert-butyldimethylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;
4-(morpholinomethyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3-((3,5-bis(trifluoromethyl)phenyl)ethynyl)phenyl)thiazol-2-yl)-4-(morpholinomethyl)benzamide;
N-(4-(3-((tert-butyldimethylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-(morpholinomethyl)benzamide;
N-(4-(3-((tert-butyldiphenylsilyl)ethynyl)phenyl)thiazol-2-yl)-4-(morpholinomethyl)benzamide;
4-((4-methylpiperazin-1-yl)methyl)-N-(4-(3-((2-(trifluoromethoxy)phenyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
5-(4-(4-methylpiperazine-1-carbonyl)phenyl)-N-(4-(3-((2-(trifluoromethoxy)phenyl)ethynyl)phenyl)thiazol-2-yl)furan-2-carboxamide;
4-(((2-(dimethylamino)ethyl)amino)methyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
4-((1H-tetrazol-1-yl)methyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
4-((1H-imidazol-1-yl)methyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
isopropyl 2-((4-((4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)carbamoyl)benzyl)amino)acetate;
4-((4-methylpiperazin-1-yl)methyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide;
N-(4-(3-ethynylphenyl)thiazol-2-yl)-4-((4-methylpiperazin-1-yl)methyl)benzamide and
4-((4-(prop-2-yn-1-yl)piperazin-1-yl)methyl)-N-(4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)benzamide.

### Claim 10 (depends on 1)

The compounds of claim 1 for use as medicaments for the treatment of cancer.

### Claim 11 (depends on 1)

The compounds of claim 1 for use as medicament for the treatment of a cancer selected from the list of anaplastic large cell lymphoma (ALCL), diffuse large B cell lymphoma, inflammatory myofibroblastic tumours, non-small cell lung cancer (NSCLC), oesophageal squamous cell carcinoma, renal medullary carcinoma, myeloid leukaemia, breast cancer and colorectal carcinoma.
